Author Question: Research regarding the success of treating paraphilic disorders with procedures such as orgasmic ... (Read 62 times)

CQXA

  • Hero Member
  • *****
  • Posts: 546
Research regarding the success of treating paraphilic disorders with procedures such as orgasmic reconditioning and covert sensitization indicates that
 
  a. treatment is generally not successful.
 b. treatment is successful in only the small number of cases where the patient completes all treatment sessions.
  c. the number of cases in the research studies is too small to make conclusions at this point.
 d. treatment is generally effective.

Question 2

Treatment for paraphilic disorders is considered successful when someone has
 
  a. completed all treatment session.
 b. demonstrated no deviant sexual arousal on objective physiological testing.
  c. had no legal record of any charges of deviant sexual activity.
 d. all of the above



connor417

  • Sr. Member
  • ****
  • Posts: 329
Answer to Question 1

d

Answer to Question 2

d



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

In the United States, congenital cytomegalovirus causes one child to become disabled almost every hour. CMV is the leading preventable viral cause of development disability in newborns. These disabilities include hearing or vision loss, and cerebral palsy.

Did you know?

Amphetamine poisoning can cause intravascular coagulation, circulatory collapse, rhabdomyolysis, ischemic colitis, acute psychosis, hyperthermia, respiratory distress syndrome, and pericarditis.

Did you know?

The top five reasons that children stay home from school are as follows: colds, stomach flu (gastroenteritis), ear infection (otitis media), pink eye (conjunctivitis), and sore throat.

Did you know?

Persons who overdose with cardiac glycosides have a better chance of overall survival if they can survive the first 24 hours after the overdose.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library